Navigation Links
HeartSine® Technologies Named One of the Most Innovative Businesses in the United Kingdom
Date:9/6/2011

NEWTOWN, Pa., Sept. 6, 2011 /PRNewswire/ -- HeartSine® Technologies, Inc., a world leader in personal and public access defibrillators, announced that it is a finalist to receive the coveted Orange Innovation Award in the 10th annual UK National Business Awards. HeartSine was selected because of its innovative approach to the design, development and manufacture of Automated External Defibrillators (AED) for the treatment of Sudden Cardiac Arrest.

The Orange Innovation Award recognizes businesses that have gone beyond the ordinary in their development and who have implemented cutting edge innovation in terms of products, services or company culture. The clinically advanced technology within HeartSine's leading edge cardiac defibrillation products enables the company to compete successfully in the global healthcare market.

HeartSine's Public Access Defibrillator (PAD) devices meet and exceed AED clinical efficacy standards. This innovation enables HeartSine to provide its global customers with exceptional product reliability, the lowest cost of ownership and superior technology that helps save lives.

"Our long history of invention and innovation in the AED industry continues today in our ongoing commitment to developing and providing the highest level of clinically advanced, lifesaving technology to customers around the globe," said Marc Lawrence, senior vice president, HeartSine. "We are honored to have been selected as a finalist for this prestigious award."

HeartSine will prepare a presentation in person before an independent panel of experts in October. Winners will be announced in November at an awards ceremony in London.  

About HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care. HeartSine® samaritan® PAD (Public Access Defibrillator) is the only medical device specifically designed for public access use to administer lifesaving treatment for Sudden Cardiac Arrest. It's lifesaving, pure and simple.

For more information, please contact info@heartsine.com, call (866) 478-7463, ext. 112, or visit www.heartsine.com.

Download a high-res photo of the samaritan® PAD 300P: http://www.ggcomm.com/HeartSine/PAD300P.jpg

121 Friends Lane
Suite 400
Newtown, PA 18940
Phone: 215.860.8100 ext. 112
Contact: Stacey Lock
stacey.lock@heartsine.com


'/>"/>
SOURCE HeartSine Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shock for Life and HeartSine® Technologies Now Exclusive Providers of Lifesaving AED Solution to Wegmans Food Markets
2. HeartSine® Technologies Donates Lifesaving AED to Camphill Special School
3. HeartSine® Increases AED System Warranty to Longest in the Industry
4. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
5. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
6. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
7. China Medical Technologies Reports First Fiscal Quarter Financial Results
8. Patient Safety Technologies Reports Second Quarter 2011 Results
9. Deloitte Stakes Claim in Drug Safety & Regulatory Consulting Market With Acquisition of Intrasphere Technologies, Inc. Assets
10. Althea Technologies Hosts Health and Wellness Week
11. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... has announced the addition of the "Ovarian Cancer Drugs Price Analysis ... The latest research Ovarian Cancer Drugs Price Analysis and Strategies - 2016, ... The research answers the following questions: ... clinical attributes? How are they positioned in the Global Ovarian Cancer market? ...
(Date:2/28/2017)... , Feb. 28, 2017  Rigel Pharmaceuticals, Inc. (Nasdaq: ... will report its fourth quarter and year end ... 7, 2017.  Rigel senior management will follow the ... at 5:00pm Eastern Time (2:00pm Pacific Time) to ... access the live conference call by dialing 855-892-1489 ...
(Date:2/28/2017)... FRANCISCO , February 27, 2017 ... D BioMedical assets for ... LOI contemplates capital infusion into Amarantus ...   Amarantus names four new appointees to its Board of ... SeD Biomedical Inc. (SeD Biomedical) , a ...
Breaking Medicine Technology:
(Date:2/28/2017)... ... February 28, 2017 , ... In 2014, Harvard researchers published ... approximately 800 deaths from prostate cancer, the researchers found that men who had undergone ... to get fatal prostate cancer. Although the increased risks are small, they seem to ...
(Date:2/28/2017)... Pekin, IL (PRWEB) , ... February 28, 2017 ... ... over the past decade, has challenges as they transition from military to civilian ... population of over two million who experience poorer health and greater occurrence of ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Robert E. ... large medical group. But his impoverished upbringing and life experiences could have led him ... a Physician: Insightful and Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares ...
(Date:2/27/2017)... ... February 27, 2017 , ... Orange County dentist, Dr. A. Rassouli, ... that occurs when the bacteria in plaque infect the gums and other tissues supporting ... and root planing or SRP, and can include surgical therapies if the condition has ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine ... programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce ... hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and ...
Breaking Medicine News(10 mins):